Back to Journals » Journal of Hepatocellular Carcinoma » Volume 4

Open-label phase II clinical trial in 75 patients with advanced hepatocellular carcinoma receiving daily dose of tableted liver cancer vaccine, hepcortespenlisimut-L

Total article views   Abstract views HTML views PDF downloads Totals
6,373 Dovepress* 4,312 1,235+ 449 5,547
PubMed Central* 0 826 126 826
Totals 4,312 2,061 575 6,373
*Since 12 April 2017
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
210 0 0 0 2 208

View citations on PubMed Central and Google Scholar